Cell Free DNA in Mature B-cell Lymphoma
- Conditions
- Mature B-Cell Lymphoma
- Interventions
- Procedure: peripheral blood collection
- First Posted Date
- 2019-09-12
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT04088422
- Locations
- 🇨🇳
Ruijin hospital, Shanghai, Shanghai, China
Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma
- Conditions
- Lymphoma, Non-HodgkinGranulocyte Colony-Stimulating FactorCost-Benefit Analysis
- Interventions
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT04083079
- Locations
- 🇨🇳
Ruijin hospital, Shanghai, Shanghai, China
A Registry Study in Lymphoma Patients Treated With Liposomal Doxorubicin
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT04069845
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04072042
- Locations
- 🇨🇳
Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Biomarker Guided Treatment in DLBCL
- Conditions
- Diffuse Large B Cell Lymphoma
- Interventions
- First Posted Date
- 2019-07-19
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 128
- Registration Number
- NCT04025593
- Locations
- 🇨🇳
Ruijin hospital, Shanghai, Shanghai, China
3D Reconstruction in Video-assisted Thoracoscopic Surgery (VATS) Segmentectomy
- Conditions
- Segmentectomy
- Interventions
- Other: 3D reconstruction
- First Posted Date
- 2019-07-02
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 191
- Registration Number
- NCT04004494
- Locations
- 🇨🇳
Guangdong General Hospital, Guangdong, Guangdong, China
🇨🇳Union Hospital of Fujian medical university, Fujian, Fujian, China
🇨🇳Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, Shanghai, China
Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer
- Conditions
- Dose-escalationMediastinal Lymph Node RecurrenceEsophageal CancerSalvage Radiotherapy
- Interventions
- Radiation: treatment group(phase I)Radiation: treatment group (phase II)
- First Posted Date
- 2019-06-19
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 46
- Registration Number
- NCT03990532
- Locations
- 🇨🇳
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
DACAB Trial: Follow-up Extension
- Conditions
- Coronary Artery Bypass GraftingAntiplatelet Therapy
- First Posted Date
- 2019-06-17
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT03987373
- Locations
- 🇨🇳
Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China
🇨🇳Nan Jing First Hospital, Nanjing, Jiangsu, China
🇨🇳Jiangsu Province Hospital, Nanjing, Jiangsu, China
Quantitative Flow Ratio (QFR) Guided Revascularization Strategy for Patients Undergoing Primary Valve Surgery With Comorbid Coronary Artery Disease
- Conditions
- Planned to Undergo Elective On-pump Valve Surgery Due to Primary Mitral and/or Aortic Valvular Heart DiseasePrimary Valvular Heart Disease With Comorbid Coronary Artery Disease
- Interventions
- Device: QFR-guided strategyOther: CAG-guided strategy
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 792
- Registration Number
- NCT03977129
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
🇨🇳The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer
- First Posted Date
- 2019-05-22
- Last Posted Date
- 2021-04-30
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 231
- Registration Number
- NCT03959150
- Locations
- 🇨🇳
Department of Oncology, Ruijin Hospital, Shanghai, China